Maite Verreault

Maite Verreault

UNVERIFIED PROFILE

Are you Maite Verreault?   Register this Author

Register author
Maite Verreault

Maite Verreault

Publications by authors named "Maite Verreault"

Are you Maite Verreault?   Register this Author

18Publications

397Reads

19Profile Views

Temporary blood-brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma.

J Neurooncol 2019 Aug 13;144(1):33-41. Epub 2019 Jun 13.

Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin, 75013, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-019-03204-0DOI Listing
August 2019

ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma.

J Neurooncol 2018 Jul 8;138(3):479-486. Epub 2018 Mar 8.

Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 04 UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, 75013, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-018-2819-3DOI Listing
July 2018

Blood-brain barrier, cytotoxic chemotherapies and glioblastoma.

Expert Rev Neurother 2016 11 4;16(11):1285-1300. Epub 2016 Jul 4.

a Inserm U 1127, CNRS UMR 7225 , Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM , Paris , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737175.2016.1202761DOI Listing
November 2016

Preclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2-Amplified and TP53 Wild-type Glioblastomas.

Clin Cancer Res 2016 Mar 19;22(5):1185-96. Epub 2015 Oct 19.

Inserm, U 1127, Paris, France. CNRS, UMR 7225, Paris, France. Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, Paris, France. Institut du Cerveau et de la Moëlle épinière, ICM, 47, Bd de l'Hôpital, Paris, France. AP-HP, Hôpital universitaire Pitié-Salpêtrière, Service de Neurologie 2-Mazarin, 47, Bd de l'Hôpital, Paris, France. AP-HP, Hôpital de la Pitié-Salpêtrière, Service de Neuropathologie R Escourolle, 47, Bd de l'Hôpital, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-1015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4842012PMC
March 2016

[Adult diffuse glioma: genetic heterogeneity and therapeutic implications].

Med Sci (Paris) 2012 Oct 12;28(10):813-6. Epub 2012 Oct 12.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1051/medsci/20122810005DOI Listing
October 2012

Lipid-based nanoformulation of irinotecan: dual mechanism of action allows for combination chemo/angiogenic therapy.

Nanomedicine (Lond) 2011 Nov;6(9):1645-54

BC Cancer Agency, Department of Experimental Therapeutics, 675 West 10th Avenue, Vancouver BC Canada, V5Z 1L3.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/nnm.11.140DOI Listing
November 2011

Gene silencing in the development of personalized cancer treatment: the targets, the agents and the delivery systems.

Curr Gene Ther 2006 Aug;6(4):505-33

Advanced Therapeutics, British Columbia Cancer Agency, 675 West 10 Avenue, Vancouver, BC V5Z 1L3, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/156652306777934838DOI Listing
August 2006